Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMRV4DT)

Drug Name

AT1001 Drug Info

Synonyms

Larazotide acetate; Larazotide acetate [USAN]; AT-1001; 881851-50-9; Larazotide acetate (USAN); UNII-FO8S2IW40N; AT 1001; FO8S2IW40N; CHEMBL2103815; NYGCNONRVCGHAT-UFIKZEAMSA-N; HY-106268A; CS-8047; D09352; Glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolylglycine acetate; Glycine, glycylglycyl-L-valyl-L-leucyl-L-valyl-L-glutaminyl-L-prolyl-, monoacetate

Indication

Disease Entry	ICD 11	Status	REF
Autoimmune diabetes	5A10	Phase 3	[1]

Cross-matching ID

PubChem CID: 44146842
CAS Number: CAS 881851-50-9
TTD Drug ID: DMRV4DT

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
Haptoglobin (HP)	TTLC8E1	HPT_HUMAN	Modulator	[2]

------------------------------------------------------------------------------------

References

1	ClinicalTrials.gov (NCT00925301) Study of the Effects of Oral AT1001 (Migalastat Hydrochloride) in Patients With Fabry Disease. U.S. National Institutes of Health.
2	Zonulin, regulation of tight junctions, and autoimmune diseases